Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
37
WVE Quote, Financials, Valuation and Earnings
Last price:
$17.91
Seasonality move
:
-15.64%
Day range:
$7.39 - $7.71
52-week range:
$5.28 - $15.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.43x
P/B ratio:
10.05x
Volume:
2.6M
Avg. volume:
3.1M
1-year change:
-48.13%
Market cap:
$1.3B
Revenue:
$108.3M
EPS (TTM):
-$0.75
Analysts' Opinion
-
Consensus RatingWave Life Sciences Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.80, Wave Life Sciences Ltd. has an estimated upside of 164.35% from its current price of $7.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $7.49.
Fair Value
-
According to the consensus of 14 analysts, Wave Life Sciences Ltd. has 164.35% upside to fair value with a price target of $19.80 per share.
WVE vs. S&P 500
-
Over the past 5 trading days, Wave Life Sciences Ltd. has underperformed the S&P 500 by -3.78% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Wave Life Sciences Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Wave Life Sciences Ltd. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Wave Life Sciences Ltd. reported revenues of $7.6M.
Earnings Growth
-
Wave Life Sciences Ltd. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Wave Life Sciences Ltd. reported earnings per share of -$0.32.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
11.43x
EV / EBIT:
--
EV / Revenue:
9.92x
PEG ratio (5yr expected):
-0.15x
EV / Free cash flow:
-5.41x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$100.5M
Return On Assets:
-40.85%
Net Income Margin (TTM):
-111.64%
Return On Equity:
-73.8%
Return On Invested Capital:
-64.6%
Operating Margin:
-740.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $85.5M | $53.6M | $109.2M | -$7.7M | $7.6M | |
| Gross Profit | $76M | $44.9M | $100.5M | -$9.8M | $5.4M | |
| Operating Income | -$92.9M | -$152.1M | -$135.9M | -$63.9M | -$56.4M | |
| EBITDA | -$83.4M | -$143.4M | -$127.2M | -$61.8M | -$54.1M | |
| Diluted EPS | -$0.87 | -$1.11 | -$0.75 | -$0.47 | -$0.32 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $158M | $131.4M | $158.6M | $324.5M | $215.5M | |
| Total Assets | $200.5M | $181.5M | $199.9M | $358.5M | $241.4M | |
| Current Liabilities | $31.6M | $64.3M | $100M | $170.7M | $85.9M | |
| Total Liabilities | $162.7M | $178.2M | $232.5M | $209M | $109M | |
| Total Equity | $37.8M | $3.4M | -$32.6M | $149.5M | $132.4M | |
| Total Debt | $26.6M | $33.7M | $27.2M | $19.8M | $11.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$20.5M | -$141.9M | -$199.6M | -$48.2M | -$45.8M | |
| Cash From Investing | $23.7M | -$1.2M | -$811.4K | -$396.5K | -$254.1K | |
| Cash From Financing | $39.1M | $315.3M | $82.4M | $206.7M | $33.4M | |
| Free Cash Flow | -$21.5M | -$143.1M | -$200.4M | -$48.6M | -$46.1M | |
WVE
Sector
Market Cap
$1.3B
$28.5M
Price % of 52-Week High
47.65%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-6.87%
-1.33%
1-Year Price Total Return
-48.13%
-20.32%
Beta (5-Year)
-1.719
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$7.44
200-day SMA
Sell
Level
$7.76
Bollinger Bands (100)
Sell
Level
6.99 - 8.81
Chaikin Money Flow
Buy
Level
1.5M
20-day SMA
Buy
Level
$7.24
Relative Strength Index (RSI14)
Buy
Level
51.22
ADX Line
Buy
Level
19.21
Williams %R
Neutral
Level
-24.4218
50-day SMA
Sell
Level
$7.49
MACD (12, 26)
Buy
Level
1.52
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Sell
Level
-429.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.9874)
Sell
CA Score
(Annual)
Level (-2.2736)
Buy
Beneish M-Score
(Annual)
Level (-2.8288)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.2766)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Stock Forecast FAQ
In the current month, WVE has received 13 Buy ratings 1 Hold ratings, and 0 Sell ratings. The WVE average analyst price target in the past 3 months is $19.80.
-
Where Will Wave Life Sciences Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Wave Life Sciences Ltd. share price will rise to $19.80 per share over the next 12 months.
-
What Do Analysts Say About Wave Life Sciences Ltd.?
Analysts are divided on their view about Wave Life Sciences Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Wave Life Sciences Ltd. is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Wave Life Sciences Ltd.'s Price Target?
The price target for Wave Life Sciences Ltd. over the next 1-year time period is forecast to be $19.80 according to 14 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is WVE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Wave Life Sciences Ltd. is a Buy. 13 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of WVE?
You can purchase shares of Wave Life Sciences Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Wave Life Sciences Ltd. shares.
-
What Is The Wave Life Sciences Ltd. Share Price Today?
Wave Life Sciences Ltd. was last trading at $17.91 per share. This represents the most recent stock quote for Wave Life Sciences Ltd.. Yesterday, Wave Life Sciences Ltd. closed at $7.49 per share.
-
How To Buy Wave Life Sciences Ltd. Stock Online?
In order to purchase Wave Life Sciences Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get WVE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
WVE
Sector
P/E ratio
--
23.75x
PEG ratio
-0.15x
-0.01x
P/B ratio
10.05x
1.83x
Price / LTM sales
11.43x
1.60x
Growth Metrics
WVE
Sector
Revenue growth
199.11%
4.85%
Earnings growth
31.12%
11.11%
Revenue (5-year growth)
46.62%
6.45%
Earnings forecast
-$0.31
-$0.20
Profitability
WVE
Sector
Profitability FY 2024
$99.6M
$3.6M
Return on invested capital
-64.6%
-30.98%
Return on assets
-40.85%
-27.62%
Return on equity
-73.8%
-36.69%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Feb
9
Balance Sheet
WVE
Sector
Total cash
$196.2M
$27.2M
Short term investments
--
$25.7M
Total assets
$352.2M
$79.7M
Long term debt
$11.4M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 3.46% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 47.95% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 10.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
